Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study

Citation:
Mansour, S. M., Rehab N. Shamma, K. A. Ahmed, N. A. Sabry, G. Esmat, A. A. Mahmoud, and A. Maged, "Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study", International Immunopharmacology, vol. 99, pp. 1-11, 2021.